After the severe winter, the season has arrived for the elderly to go outdoors. But how many elderly people are unable to move freely because of their knees and can only feel envious in this wonderful season. The Department of Rheumatology and Immunology of Xinxiang Central Hospital carries out 10-day osteoarthritis relief treatment and continuous drug control to enable elderly patients with knee osteoarthritis to obtain continuous symptom relief and find joy in life. Fan Wenqiang, Department of Rheumatology and Immunology, Xinxiang Central Hospital, Henan Province, China Osteoarthritis is a chronic joint disease characterized by degeneration and destruction of joint cartilage and osteophytes. Studies have shown that the prevalence of osteoarthritis is 10%-17% in people aged 40, 50% in people aged 60 and above, and 80% in people aged 75 and above. The ultimate disability rate of the disease is 53%. Clinical symptoms include joint swelling and pain, osteophytes and limited movement. The treatment of osteoarthritis in the Department of Rheumatology and Immunology is based on the original joint cavity drug injections to relieve symptoms, and a new concept in the treatment of osteoarthritis —-DMOADs drug therapy. Such drugs can stop the damage to joint structures and slow down the disease process, while also reducing the patient’s pain symptoms. The concept of individualized treatment targeting patients with aggressive topical medication, local treatment and physiotherapy, adequate amount and duration of DMOADs, minimal effective amount of NSAIDs medication and life coaching (proper exercise and weight reduction, etc.) has enabled many patients with osteoarthritis to expand their range of motion and reduce joint pain. Life is more enriching.